BeOne Medicines Ownership | Who Owns BeOne Medicines?
BeOne Medicines Ownership Summary
BeOne Medicines is owned by 31.54% institutional investors, 17.29% insiders, and 51.17% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 8.07% of ONC shares.
ONC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BeOne Medicines | 31.54% | 17.29% | 51.17% |
| Sector | Healthcare Stocks | 35.49% | 11.78% | 52.72% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 8.80M | 8.07% | $2.61B |
| Primecap management co/ca/ | 4.98M | 4.56% | $1.48B |
| Capital investors | 4.16M | 3.81% | $1.23B |
| Fmr | 3.69M | 3.39% | $1.10B |
| Thomas j. herzfeld advisors | 2.05M | 1.86% | $29.00M |
| Capital world investors | 1.62M | 1.49% | $481.89M |
| Hhlr advisors | 1.03M | 0.95% | $307.16M |
| Citadel advisors | 1.03M | 0.95% | $306.56M |
| Temasek (private) | 862.64K | 0.79% | $256.18M |
| Blackrock funding, inc. /de | 657.50K | 0.60% | $195.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Hhlr advisors | 1.03M | 18.36% | $307.16M |
| Baker bros. advisors lp | 8.80M | 15.00% | $2.61B |
| Thomas j. herzfeld advisors | 2.05M | 9.81% | $29.00M |
| Patient square capital lp | 80.54K | 4.24% | $23.92M |
| Healthinvest partners ab | 41.72K | 3.92% | $12.14M |
| Nan fung group | 15.72K | 3.85% | $4.67M |
| Siren | 465.00K | 3.83% | $138.09M |
| Jgp global gestao de recursos ltda. | 1.71K | 2.19% | $508.12K |
| Primecap management co/ca/ | 4.98M | 1.16% | $1.48B |
| Slow capital | 28.49K | 1.10% | $8.46M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Thomas j. herzfeld advisors | 2.05M | 9.81% | 2.05M |
| Capital world investors | 1.62M | 0.07% | 1.62M |
| Citadel advisors | 1.03M | 0.05% | 498.78K |
| Ubs group | 415.33K | 0.02% | 263.24K |
| Millennium management | 204.85K | 0.03% | 173.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | 4.16M | 0.29% | -955.14K |
| Price t rowe associates inc /md/ | 539.77K | 0.02% | -832.91K |
| Fmr | 3.69M | 0.06% | -299.02K |
| Jain global | 1.67K | 0.00% | -95.67K |
| Qube research | - | - | -94.85K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Thomas j. herzfeld advisors | 2.05M | 9.81% | 2.05M | $29.00M |
| Capital world investors | 1.62M | 0.07% | 1.62M | $481.89M |
| North ground capital | 135.32K | 0.95% | 135.32K | $1.91M |
| Arete wealth advisors | 99.33K | 0.09% | 99.33K | $1.40M |
| Resources investment advisors, llc. | 97.13K | 0.01% | 97.13K | $1.37M |
Sold Out
| Holder | Change |
|---|---|
| Cullen/frost bankers | -1.00 |
| Hm payson | -2.00 |
| Ancora advisors | -4.00 |
| Elyxium wealth | -6.00 |
| Reyes financial architecture | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 290 | -19.22% | 34,397,333 | -32.01% | 31 | 1.50% | 136 | -41.38% | 97 | 34.72% |
| Dec 31, 2025 | 154 | -44.80% | 12,358,898 | -62.55% | 11 | 1.25% | 87 | -43.87% | 40 | -48.72% |
| Sep 30, 2025 | 279 | 10.71% | 32,997,831 | -4.21% | 29 | 2.97% | 155 | 30.25% | 78 | -8.24% |
| Jun 30, 2025 | 252 | -8.70% | 34,449,266 | -19.00% | 31 | 2.01% | 119 | -21.71% | 85 | 8.97% |
| Mar 31, 2025 | 276 | 16.95% | 42,530,835 | -2.67% | 39 | 2.35% | 152 | 36.94% | 78 | -1.27% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 13, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $103.16K |
| Apr 08, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $103.45K |
| Mar 11, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $102.30K |
| Feb 04, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $348.60K |
| Feb 04, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $231.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 47 |
| 2025 Q3 | - | 42 |
| 2025 Q2 | - | 38 |
ONC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools